Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles.

Galliher-Beckley AJ, Williams JG, Collins JB, Cidlowski JA.

Mol Cell Biol. 2008 Dec;28(24):7309-22. doi: 10.1128/MCB.00808-08. Epub 2008 Oct 6.

2.

Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease.

Galliher-Beckley AJ, Cidlowski JA.

IUBMB Life. 2009 Oct;61(10):979-86. doi: 10.1002/iub.245. Review.

3.

Association of glycogen synthase kinase-3β with Parkinson's disease (review).

Li DW, Liu ZQ, Chen W, Yao M, Li GR.

Mol Med Rep. 2014 Jun;9(6):2043-50. doi: 10.3892/mmr.2014.2080. Epub 2014 Mar 28. Review.

4.

Glycogen synthase kinase 3: a key regulator of cellular fate.

Forde JE, Dale TC.

Cell Mol Life Sci. 2007 Aug;64(15):1930-44. Review.

PMID:
17530463
5.

Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer.

Walz A, Ugolkov A, Chandra S, Kozikowski A, Carneiro BA, O'Halloran TV, Giles FJ, Billadeau DD, Mazar AP.

Clin Cancer Res. 2017 Apr 15;23(8):1891-1897. doi: 10.1158/1078-0432.CCR-15-2240. Epub 2017 Jan 4. Review.

PMID:
28053024
6.

Natural and synthetic bioactive inhibitors of glycogen synthase kinase.

Khan I, Tantray MA, Alam MS, Hamid H.

Eur J Med Chem. 2017 Jan 5;125:464-477. doi: 10.1016/j.ejmech.2016.09.058. Epub 2016 Sep 20. Review.

PMID:
27689729
7.

Glycogen synthase kinase-3: a potential preventive target for prostate cancer management.

Li B, Thrasher JB, Terranova P.

Urol Oncol. 2015 Nov;33(11):456-63. doi: 10.1016/j.urolonc.2015.05.006. Epub 2015 Jun 4. Review.

8.

Glycogen synthase kinase-3 beta; a new target in pancreatic cancer?

Garcea G, Manson MM, Neal CP, Pattenden CJ, Sutton CD, Dennison AR, Berry DP.

Curr Cancer Drug Targets. 2007 May;7(3):209-15. Review.

PMID:
17504118
9.

GSK-3: tricks of the trade for a multi-tasking kinase.

Doble BW, Woodgett JR.

J Cell Sci. 2003 Apr 1;116(Pt 7):1175-86. Review.

10.

Glycogen Synthase Kinase 3: A Kinase for All Pathways?

Patel P, Woodgett JR.

Curr Top Dev Biol. 2017;123:277-302. doi: 10.1016/bs.ctdb.2016.11.011. Epub 2016 Dec 28. Review.

PMID:
28236969
11.

Glucocorticoid receptor physiology.

Heitzer MD, Wolf IM, Sanchez ER, Witchel SF, DeFranco DB.

Rev Endocr Metab Disord. 2007 Dec;8(4):321-30. Review.

PMID:
18049904
12.

GSK-3 as potential target for therapeutic intervention in cancer.

McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Sokolosky M, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Rakus D, Gizak A, Demidenko ZN, Cocco L, Martelli AM, Cervello M.

Oncotarget. 2014 May 30;5(10):2881-911. Review.

13.

Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes.

MacAulay K, Woodgett JR.

Expert Opin Ther Targets. 2008 Oct;12(10):1265-74. doi: 10.1517/14728222.12.10.1265 . Review.

14.

The GSK-3 family as therapeutic target for myocardial diseases.

Lal H, Ahmad F, Woodgett J, Force T.

Circ Res. 2015 Jan 2;116(1):138-49. doi: 10.1161/CIRCRESAHA.116.303613. Review.

15.

Dynamic regulation of glucocorticoid signalling in health and disease.

Biddie SC, Conway-Campbell BL, Lightman SL.

Rheumatology (Oxford). 2012 Mar;51(3):403-12. doi: 10.1093/rheumatology/ker215. Epub 2011 Sep 3. Review.

16.

The role of glucocorticoid receptors in metabolic syndrome and psychiatric illness.

Moraitis AG, Block T, Nguyen D, Belanoff JK.

J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):114-120. doi: 10.1016/j.jsbmb.2016.03.023. Epub 2016 Mar 18. Review.

17.

Phosphoproteomics links glycogen synthase kinase-3 to RNA splicing.

Khoa LTP, Dou Y.

J Biol Chem. 2017 Nov 3;292(44):18256-18257. doi: 10.1074/jbc.H117.813527. Review.

18.

Xenobiotics and the Glucocorticoid Receptor.

Gulliver LS.

Toxicol Appl Pharmacol. 2017 Mar 15;319:69-79. doi: 10.1016/j.taap.2017.02.003. Epub 2017 Feb 4. Review.

PMID:
28174120
19.

Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions.

Saraswati AP, Ali Hussaini SM, Krishna NH, Babu BN, Kamal A.

Eur J Med Chem. 2018 Jan 20;144:843-858. doi: 10.1016/j.ejmech.2017.11.103. Epub 2017 Dec 9. Review.

20.

The glucocorticoid receptor signalling in breast cancer.

Moutsatsou P, Papavassiliou AG.

J Cell Mol Med. 2008 Jan-Feb;12(1):145-63. Epub 2007 Dec 5. Review.

Supplemental Content

Support Center